Emergency Department Re-Presentation for @entity955 and XXXX .

@entity1 @entity64 @entity63 @entity341 @entity956 @entity955
BACKGROUND: Identification and appropriate management of @entity1 with @entity955 ( @entity955 ) is critical to mitigate the consequences of the disease. We sought to assess the frequency and pattern of the @entity341 ( @entity341 ) use by @entity1 who presented with @entity955 and/or @entity956 ( @entity956 ) in a midsized Canadian hospital. METHODS: We conducted a retrospective cohort analysis of @entity1 who presented to the @entity341 with @entity955 and/or @entity956 during the calendar years 2010-2012. @entity1 were identified using the MUSE (General Electric Healthcare, Bucks, United Kingdom) electrocardiogram database and matched with the National Ambulatory Care Reporting System and Discharge Abstract Database up to and including December 31, 2013, a follow-up period of 12 months. The number of presentations and time between visits was assessed. Admissions were identified and lengths of stay and reason for admission were recorded. RESULTS: We identified 1361 @entity1 who represented a total of 4783 visits to the @entity341 , a mean of 2.8    2.9 visits per @entity1 with 949 (69.7%) who returned for a subsequent @entity341 visit in the subsequent 12  months. Mean time between base and subsequent visits was 136.8    114.2 days. @entity341 visits generated 1462 admissions (63.0% at repeat @entity341 visits); mean length of stay was 9.7    16.0 days. @entity64 or transient @entity63 attack accounted for 80 return visits and 8 deaths in 77 @entity1 , 74% of whom with subtherapeutic or no anticoagulation medication. CONCLUSIONS: Presentation to the @entity341 with @entity955 and/or @entity956 , either as a primary reason for consultation or as a secondary diagnosis, was associated with a high risk of subsequent re-presentation and hospital admission.
